European Society for Radiotherapy and Oncology

Founded in 1980, ESTRO exists to advance all aspects of radiation oncology through a range of activities for its members and the wider healthcare and patient communities.

Website
http://www.estro.org/Pages/default.aspx

Subscribe to rss feed

Oncology & Cancer

Radiotherapy doubles survival for patients with mesothelioma

Mesothelioma patients are twice as likely to survive for two years or longer, if they are treated with a high dose of radiation to the affected side of the trunk, according to research presented at the ESTRO 38 conference.

page 1 from 5